New DSCSA Compliance Blueprint Includes FDA & Industry Input

By Eric Marshall and Zach Howard

As we approach the final phase of a 10-year rollout of the Drug Supply Chain Security Act (DSCSA), which aims to create a more secure, interoperable drug supply chain in the U.S., pharma manufacturers, distributors, and pharmacies must all ensure they are ready for its full implementation starting on Nov. 27, 2023. Specifically, the DSCSA requires all trading partners in the pharma supply chain — that is, manufacturers, wholesalers, and dispensers — to implement secure, interoperable electronic systems and processes to uniquely serialize each individual drug package in the supply chain and trace its distribution.